Viral vectors for modulating gene expression in neurons

Current Opinion in Neurobiology

Volumn 6, Issue 5, 1996, Pages 576-583

  Slack, Ruth S ^a   Miller, Freda D ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; CELL MEDIATED CYTOTOXICITY; GENE EXPRESSION; GENE TRANSFER; HELPER VIRUS; HERPES SIMPLEX VIRUS 1; NERVE CELL; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS RECOMBINANT;

EID: 0030272971     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(96)80088-2     Document Type: Article

References (53)

1. of special interest Karpati G, Lochmuller H, Nalbantoglu J, Durham H. The principles of gene therapy for the nervous system. Trends Neurosci. 19:1996;49-54 A comparison of a number of current viral gene-transfer vectors that transduce postmitotic neurons, and an evaluation of their usefulness in gene therapy.
2. of special interest Fink DJ, DeLuca NA, Goins WF, Glorioso JC. Gene transfer to neurons using herpes simplex virus-based vectors. Annu Rev Neurosci. 19:1996;265-287 Detailed review of current approaches to the development of HSV1-derived vectors and of experiments that have used these vectors to transduce neurons.
3. Kotin RM. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther. 5:1994;793-801.
4. Liljestrom P, Garoff H. A new generation of animal cell expression vectors based on the semliki forest virus replicon. Biotechnology. 9:1991;1356-1361.
5. Ali M, Lemoine NR, Ring CJA. The use of DNA viruses as vectors for gene therapy. Gene Ther. 1:1994;367-384.
6. Geller AI, Breakefield XO. A defective HSV1 vector expresses Escherichia coli beta-galactosidase in cultured neurons. Science. 241:1988;1667-1669.
7. Post LE, Roizman B. A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus is not essential for growth. Cell. 25:1991;227-232.
8. Spaete RR, Frenkel N. The herpes simplex virus amplicon: a new eukaryotic defective-virus cloning-amplifying vector. Cell. 30:1982;285-304.
9. Geller AI, Keyomarsi K, Bryan J, Pardee AB. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci USA. 87:1990;8950-8954.
10. Leib DA, Olivo PD. Gene delivery to neurons: is herpes simplex virus the right tool for the job? Bioessays. 15:1993;547-554.
11. Breakefield XO. Gene delivery into the brain using virus vectors. Nature. 3:1993;187-189.
12. Bergold PJ, Casaccia-Bonnefil P, Zeng XL, Federoff HJ. Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes virus vector expressing the GluR6 subunit of the kinetics receptor. Proc Natl Acad Sci USA. 90:1993;6165-6169.
13. Federoff HJ, Geschwind MD, Geller AL, Kessler JA. Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci USA. 89:1992;1636-1640.
14. Geschwind MD, Kessler JA, Geller AI, Federoff HJ. Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Mol Brain Res. 24:1994;327-335.
15. Battleman DS, Geller AI, Chao MV. HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J Neurosci. 13:1993;941-951.
16. Ho DY, Mocarski ES, Sapolsky RM. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc Natl Acad Sci USA. 90:1993;3655-3659.
17. Lawrence MS, Ho DY, Dash R, Sapolsky RM. Herpes simplex virus vector overexpressing the glucose transporter gene protect against seizure-induced neuron loss. Proc Natl Acad Sci USA. 92:1995;7247-7251.
18. of special interest Lawrence MS, Ho DY, Sun GH, Steinberg GK, Sapolsky RM. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci. 16:1996;486-496 The authors use HSV1-derived amplicons to overexpress the apoptosis-inhibitory protein Bcl-2 in primary cultures of hippocampal neurons and in the hippocampus in vivo. Their results indicate that overexpression of Bcl-2 inhibits neuronal apoptosis in response to a variety of insults.
19. During MJ, Naegele JR, O'Malley KL, Geller AI. Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science. 266:1994;1399-1403.
20. Anderson JK, Garber DA, Meaney CA, Breakefield XO. Gene transfer into mammalian central nervous system using Herpes virus vectors: extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter. Hum Gene Ther. 3:1992;487-499.
21. Pakzaban P, Chiocca EA. Nerve growth factor protects against Herpes simplex virus type 1 neurotoxicity in the rat striatum. Neuroreport. 5:1994;993-996.
22. Ho DY, Mocarski ES. Beta-galactosidase as a marker in the peripheral and nervous tissues of the herpes simplex virus-infected mouse. Virology. 174:1988;279-283.
23. of outstanding interest Nilaver G, Muldoon LL, Kroll RS, Pagel MA, Breakefield XO, Davidson BL, Neuwelt EA. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood - brain barrier disruption. Proc Natl Acad Sci USA. 92:1995;9829-9833 In this study, the authors compare the efficacy of adenovirus- and HSV1-derived vectors after delivery to brain tumors and the intact brain. These vectors are compared with respect to their ability to infiltrate tumor tissue and their cytotoxicity. This study raises the possibility that HSV1-derived vectors can be used to treat brain tumors.
24. Muldoon LL, Nilaver G, Kroll RA, Pagel MA, Breakefield XO, Chiocca EA, Davidson BL, Weissleder R, Neuwelt EA. Comparison of intracerebral inoculation and osmotic blood - brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain. Am J Pathol. 147:1995;1840-1851.
25. Dobson AT, Margolis AT, Sedarati F, Stevens JH, Feldman LT. A latent, nonpathogenic HSV-1 derived vector stably expresses β-galactosidase in mouse neurons. Neuron. 5:1990;353-360.
26. Johnson PA, Miyanohara A, Levine F, Cahill T, Friedmann T. Cytotoxicity of a replication-defective mutant of Herpes simplex virus type 1. J Virol. 66:1992;2952-2965.
27. Boviatsis EJ, Chase M, Wei MX, Tamiya T, Hurford RK, Kowall NW, Tepper RI, Breakefield XO, Chiocca EA. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, retrovirus vectors. Hum Gene Ther. 5:1994;183-191.
28. Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, Wei MX, Breakefield XO, Chiocca EA. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res. 54:1994;5745-5751.
29. Graham FL, Prevec L. Manipulation of adenovirus vectors. Murray EJ. Methods in Molecular Biology. 1991;109-128 The Humana Press, Totowa, New Jersey.
30. Bett AJ, Haddara W, Prevec L, Graham FL. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA. 91:1994;8802-8806.
31. Ginsberg HS. Role of early region E (E3) in pathogenesis af adenovirus disease. Proc Natl Acad Sci USA. 86:1989;3823-3827.
32. Lochmuller H, Jani A, Huard J, Prescott S, Simoneau M, Massie B, Karpati G, Acsadi G. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (ΔE1 + ΔE3) during multiple passages in 293 cells. Hum Gene Ther. 5:1994;1485-1491.
33. Acsadi G, Lochmuller H, Jani A, Huard J, Massie B, Prescott S, Simoneau M, Petrof BJ, Karpati G. Dystrophin expression in muscles of MDX mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther. 7:1996;129-140.
34. La Salle GLG, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet LD, Perricaudet M, Mallet J. An adenovirus vector for gene transfer into neurons and glia in the brain. Science. 259:1993;988-990.
35. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M, Kahn A, Peschanski M. Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3:1993;224-228.
36. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3:1993;219-223.
37. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet. 3:1993;229-234.
38. Ghadge GD, Roos RP, Kang UJ, Wollmann R, Fishman PS, Kalynych AM, Barr E, Leiden JM. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther. 2:1995;132-137.
39. of special interest Gage FH, Coates PW, Palmer TD, Kuhn HG, Fisher LJ, Suhonen JO, Peterson DA, Suhr ST, Ray J. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci USA. 92:1995;11879-11883 A recombinant adenovirus vector expressing β-galactosidase is used to `tag' primary adult neural progenitor cells before they are transplanted into the brain. This study raises the possibility that recombinant adenovirus can be used to genetically manipulate primary neural cells for use in neural transplants.
40. Yamagata M, Jaye DL, Sanes JR. Gene transfer to avian embryos with a recombinant adenovirus. Dev Biol. 166:1994;355-359.
41. of special interest Moriyoshi K, Richards LJ, Akazawa C, O'Leary DDM, Nakanishi S. Labeling neural cells using adenoviral gene transfer of membrane-targeted GFP. Neuron. 16:1996;255-260 The authors describe modifications made to GFP that enhance its fluorescence intensity in mammalian axons and dendrites. They use recombinant adenovirus vectors expressing this enhanced GFP, in addition to a membrane-anchoring signal, to label cortical neurons and their processes in culture and in vivo, and to label hippocampal neurons in organotypic slice cultures.
42. of outstanding interest Paquet L, Massie B, Mains RE. Proneuropeptide Y processing in large dense-core vesicles: manipulation of prohormone convertase expression in sympathetic neurons using adenoviruses. J Neurosci. 16:1996;964-973 One of the first studies to use recombinant adenovirus to study the biochemistry of primary neurons. Specifically, recombinant adenovirus is used to over-express processing enzymes and to examine neuropeptide Y processing.
43. of outstanding interest Slack RS, Belliveau DJ, Rosenberg M, Atwal J, Lochmüller H, Aloyz R, Haghighi A, Lach B, Seth P, Cooper E, Miller FD. Adenovirus-mediated gene transfer of the tumor suppressor, p53, induces apoptosis in postmitotic neurons. J Cell Biol. 1996; This study documents the lack of cytotoxicity of low titres of recombinant adenovirus on primary cultured neurons as monitored by cell survival, electron microscopy, and electrophysiology. Recombinant adenovirus is used to demonstrate that overexpression of p53 in postmitotic neurons leads to apoptosis.
44. Barkats M, Remelmans A, Geoffroy M, Robert J, Loquet I, Horellou R, Revah F, Mallet J. An adenovirus encoding CuZnSOD protects cultured striatal neurones against glutamate toxicity. Neuroreport. 7:1996;497-501.
45. Wilkemeyer MS, Smith KL, Zarei MM, Benke TA, Swann JW, Angelides KJ, Eisensmith RC. Adenovirus-mediated gene transfer into dissociated and explant cultures of rat hippocampal neurons. J Neurosci Res. 43:1996;161-174.
46. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA. 91:1994;6196-6200.
47. of outstanding interest Yeh P, Dedieu J, Orsini C, Vigne E, Denefle P, Perricaudet M. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J Virol. 70:1996;559-565 As in [46], new-generation adenovirus vectors with deletions in the E1 and E4 regions of the viral genome are described. These new vectors may well diminish, or potentially abolish, the cytotoxicity observed with high titres of current adenoviral vectors.
48. Olkkonen VM, Liljestrom P, Garoff H, Simons K, Dotti CG. Expression of heterologous proteins in cultured rat hippocampal neurons using the semliki forest virus vector. J Neurosci Res. 35:1993;445-451.
49. De Hoop M, Von Poser C, Lange C, Ikonen E, Hunziker W, Dotti CG. Intracellular routing of wild-type and mutated polymeric immunoglobulin receptor in hippocampal neurons in culture. J Cell Biol. 130:1995;1447-1459.
50. of special interest Simons M, De Strooper B, Multhaup G, Tiernari PJ, Dotti CG, Beyreuther K. Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J Neurosci. 16:1996;899-908 This study exploits the SFV vector to study cellular processing and routing of the human amyloid precursor protein in a number of different populations of primary neurons.
51. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8:1994;148-154.
52. Wu P, De Fiebre CM, Millard WJ, Elmstrom K, Gao Y, Meyer EM. Sendai virosomal infusion of an adeno-associated virus-derived construct containing neuropeptide Y into primary rat brain cultures. Neurosci Lett. 190:1995;73-76.
53. of outstanding interest Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:1996;263-267 The authors describe a novel HIV-derived retroviral vector that is capable of transducing terminally differentiated, postmitotic cells, including neurons in the adult brain.